These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 27546014)

  • 1. The impact of field cancerization on the extent of duct carcinoma in situ (DCIS) in breast tissue after conservative excision.
    Asioli S; Morandi L; Cavatorta C; Cucchi MC; Foschini MP
    Eur J Surg Oncol; 2016 Dec; 42(12):1806-1813. PubMed ID: 27546014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic clonal mapping of in situ and invasive ductal carcinoma indicates the field cancerization phenomenon in the breast.
    Foschini MP; Morandi L; Leonardi E; Flamminio F; Ishikawa Y; Masetti R; Eusebi V
    Hum Pathol; 2013 Jul; 44(7):1310-9. PubMed ID: 23337025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Surgical Margin Following Breast-Conserving Surgery: A Large Population-Based Cohort Study.
    van Deurzen CH
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):627-633. PubMed ID: 27590331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
    Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
    Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-menopausal Status, High Nuclear Grade, Tumor Size >30 mm and Positive Resection Margins Are Predictors of Residual Tumor After Lumpectomy for Ductal Carcinoma In Situ of the Breast.
    Joste M; Mendes V; Tixier S; Palpacuer C; Laviolle B; Leveque J; Ouldamer L
    Anticancer Res; 2015 Jun; 35(6):3471-7. PubMed ID: 26026112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying Factors and Techniques to Decrease the Positive Margin Rate in Partial Mastectomies: Have We Missed the Mark?
    Edwards SB; Leitman IM; Wengrofsky AJ; Giddins MJ; Harris E; Mills CB; Fukuhara S; Cassaro S
    Breast J; 2016 May; 22(3):303-9. PubMed ID: 26854189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of residual disease in repeat excisions for lumpectomies with margins less than 0.1 cm.
    Rodriguez N; Diaz LK; Wiley EL
    Clin Breast Cancer; 2005 Jun; 6(2):169-72. PubMed ID: 16001996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.
    Jenkinson AD; Al-Mufti RA; Mohsen Y; Berry MJ; Wells C; Carpenter R
    Eur J Surg Oncol; 2001 Feb; 27(1):21-5. PubMed ID: 11237487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Margin index is not a reliable tool for predicting residual disease after breast-conserving surgery for DCIS.
    Fisher CS; Klimberg VS; Khan S; Gao F; Margenthaler JA
    Ann Surg Oncol; 2011 Oct; 18(11):3155-9. PubMed ID: 21947593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins.
    Merrill AL; Tang R; Plichta JK; Rai U; Coopey SB; McEvoy MP; Hughes KS; Specht MC; Gadd MA; Smith BL
    Ann Surg Oncol; 2016 Oct; 23(11):3453-3458. PubMed ID: 27207096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management of ductal carcinoma in situ of the breast: A large retrospective study from a single institution.
    Miligy IM; Toss MS; Khout H; Whisker L; Burrell HC; Ellis IO; Green AR; Macmillan D; Rakha EA
    Breast J; 2019 Nov; 25(6):1143-1153. PubMed ID: 31318120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sampling of secondary margins decreases the need for re-excision after partial mastectomy.
    Guidroz JA; Larrieux G; Liao J; Sugg SL; Scott-Conner CE; Weigel RJ
    Surgery; 2011 Oct; 150(4):802-9. PubMed ID: 22000194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of extent and grade of ductal carcinoma in situ in radiologically guided core biopsy for the status of margins in lumpectomy specimens.
    Mai KT; Yazdi HM; Ford JC; Matzinger FR
    Eur J Surg Oncol; 2000 Nov; 26(7):646-51. PubMed ID: 11078610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting successful breast conservation for ductal carcinoma in situ.
    Dillon MF; Mc Dermott EW; O'Doherty A; Quinn CM; Hill AD; O'Higgins N
    Ann Surg Oncol; 2007 May; 14(5):1618-28. PubMed ID: 17443388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of radioactive iodine-125 seed localization in patients with non-palpable breast cancer: a comparison with the radioguided occult lesion localization with 99m technetium.
    van der Noordaa ME; Pengel KE; Groen E; van Werkhoven E; Rutgers EJ; Loo CE; Vogel W; Vrancken Peeters MJ
    Eur J Surg Oncol; 2015 Apr; 41(4):553-8. PubMed ID: 25707349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of multiple re-excisions after lumpectomy for breast cancer.
    Coopey S; Smith BL; Hanson S; Buckley J; Hughes KS; Gadd M; Specht MC
    Ann Surg Oncol; 2011 Dec; 18(13):3797-801. PubMed ID: 21630123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual disease after re-excision lumpectomy for close margins.
    Sabel MS; Rogers K; Griffith K; Jagsi R; Kleer CG; Diehl KA; Breslin TM; Cimmino VM; Chang AE; Newman LA
    J Surg Oncol; 2009 Feb; 99(2):99-103. PubMed ID: 19065638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens.
    Brachtel EF; Rusby JE; Michaelson JS; Chen LL; Muzikansky A; Smith BL; Koerner FC
    J Clin Oncol; 2009 Oct; 27(30):4948-54. PubMed ID: 19720921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Mammographic Density have an Impact on the Margin Re-excision Rate After Breast-Conserving Surgery?
    Edwards BL; Guidry CA; Larson KN; Novicoff WM; Harvey JA; Schroen AT
    Ann Surg Oncol; 2016 Mar; 23(3):782-8. PubMed ID: 26471488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A two-millimetre free margin from invasive tumour minimises residual disease in breast-conserving surgery.
    Ward ST; Jones BG; Jewkes AJ
    Int J Clin Pract; 2010 Nov; 64(12):1675-80. PubMed ID: 20946273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.